Dow Down 0.92% Nasdaq Down 0.83%

Enzon Pharmaceuticals Inc. (ENZN)

-NasdaqCM
0.98 0.01(0.61%) Oct 22, 4:00PM EDT
Prev Close:0.97
Open:0.96
Bid:0.86 x 300
Ask:1.10 x 14000
1y Target Est:14.00
Beta:1.94
Next Earnings Date:N/A
Day's Range:0.96 - 0.99
52wk Range:0.78 - 1.83
Volume:66,845
Avg Vol (3m):535,694
Market Cap:43.02M
P/E (ttm):1.62
EPS (ttm):0.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ENZN

Comparison

Symbol% ChgMkt Cap
ENZNUp 0.61%43.02M
ISIS4.77B
NKTR1.61B
PFE179.45B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.30
Ex-Dividend Date:24-Dec-13

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Enzon Pharmaceuticals, Inc. is engaged in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for Melanoma; Macugen for neovascular age-related macular degeneration; CIMZIA for Crohn’s disea... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback